Pfizer Inc

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturing and healthcare.

Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries

CEO Name:
Ian Read
Director, Government Relations

Contact
JD
James DeMay
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
jskelton@politicomlaw.com
http://www.pfizer.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 24
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

For
Notification Date
2/13/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 114
Assembly Bill 114
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)

Bill Text and History

For
Notification Date
2/12/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

2019 Wisconsin Act 12

For
Notification Date
2/13/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 100
Senate Bill 100
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)

Bill Text and History

For
Notification Date
8/29/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Licensing Third-Party Logistics Providers by the state of Wisconsin
Development, drafting or introduction of a proposal relating to
Licensing Third-Party Logistics Providers by the state of Wisconsin

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/19/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Step Therapy Reform
Development, drafting or introduction of a proposal relating to
Step Therapy Reform

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/6/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal relating to Step Therapy/Fail First legislation
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to Step Therapy/Fail First legislation

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/29/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal relating to health care access
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to health care access

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/29/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Substance Abuse Treatment
Development, drafting or introduction of a proposal relating to
Substance Abuse Treatment

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Pain Management Issues
Development, drafting or introduction of a proposal relating to
Pain Management Issues

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Vaccines and immunizations
Development, drafting or introduction of a proposal relating to
Vaccines and immunizations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Regulation of the Pharmaceutical Industry
Development, drafting or introduction of a proposal relating to
Regulation of the Pharmaceutical Industry

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Prescribing Opioids
Development, drafting or introduction of a proposal relating to
Prescribing Opioids

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Behavioral Health Issues
Development, drafting or introduction of a proposal relating to
Behavioral Health Issues

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Medicaid Issues
Development, drafting or introduction of a proposal relating to
Medicaid Issues

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Fetal Tissue Research Ban
Development, drafting or introduction of a proposal relating to
Fetal Tissue Research Ban

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Legal Reform Bills
Development, drafting or introduction of a proposal relating to
Legal Reform Bills

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Substitution of interchangeable biosimilars
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/13/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
Total Lobbying Expenditures 2019
January - June
$25,578.00
2019
July - December
$25,695.00
2020
January - June
$25,482.10
2020
July - December
$26,163.60
Total $102,918.70
Total Hours Communicating 2019
January - June
4.50
2019
July - December
10.00
2020
January - June
8.50
2020
July - December
38.00
Total 61.00
Total Hours Other 2019
January - June
39.00
2019
July - December
37.00
2020
January - June
54.00
2020
July - December
83.50
Total 213.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
2020
January - June
2020
July - December
Total 1%
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
5%
2020
January - June
2020
July - December
Total 2%
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
20%
2020
January - June
30%
2020
July - December
5%
Total 12%
Relating to: registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. (FE)
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
2020
January - June
30%
2020
July - December
5%
Total 9%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
2020
January - June
2020
July - December
Total 2%
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
30%
2019
July - December
20%
2020
January - June
20%
2020
July - December
20%
Total 22%
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
40%
2019
July - December
40%
2020
January - June
20%
2020
July - December
35%
Total 33%
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
15%
2020
January - June
2020
July - December
Total 3%
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
2020
January - June
2020
July - December
35%
Total 15%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures